Predictive value of high Ki‐67 expression in stage I oral squamous cell carcinoma specimens after primary surgery
Authors:
- Christian FreudlspergerCFChristian Freudlsperger
- Sandra E. RohlederSRSandra E. Rohleder
- Siegmar ReinertSRSiegmar Reinert
- Juergen HoffmannJHJuergen Hoffmann
- 11 April 2011
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 33 (5) , 668-672
Abstract
Background Until now prognostic evaluation for patients with oral squamous cell carcinoma (OSCC) remains difficult. Thus, the aim of the present study was to ascertain the value of Ki-67 expression in predicting locoregional recurrence in OSCC. Methods In a large, homogeneous study population consisting of 166 patients with OSCC exclusively treated with primary surgery, expression of Ki-67 was investigated by immunohistochemistry. Results We report that high proliferation significantly correlated to a higher risk of locoregional recurrence in stage I OSCC patients (p = .029). Carcinomas with a Ki-67 labeling index above the median showed a mean time to recurrence of 42 months, whereas mean time to recurrence was 55 months for those tumors below the median (p = .017). Conclusions This study provides the evidence of a predictive value of Ki-67 expression in stage I OSCC. Therefore, Ki-67 expression level could be used to identify a subgroup of surgically treated patients with stage I OSCC who might benefit from treatment intensification. © 2010 Wiley Periodicals, Inc. Head Neck, 2011Keywords
This publication has 16 references indexed in Scilit:
- Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinomaBritish Journal of Cancer, 2008
- Can Ki-67 Predict Recurrence of N0 Squamous Cell Carcinoma of the Tongue?Annals of Otology, Rhinology & Laryngology, 2006
- Molecular markers of head and neck squamous cell carcinoma: Promising signs in need of prospective evaluationHead & Neck, 2005
- Prognostic Relevance of Ki-67 Antigen Expression in 329 Cases of Oral Squamous Cell CarcinomaORL, 2002
- Ki67 protein: the immaculate deception?Histopathology, 2002
- HAS THE CELLULAR PROLIFERATION MARKER KI67 ANY CLINICAL RELEVANCE IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK?Clinical Otolaryngology, 1994
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.Journal of Histochemistry & Cytochemistry, 1991
- The clinical assessment of proliferation and growth in human tumours: Evaluation of methods and applications as prognostic variablesThe Journal of Pathology, 1990
- New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomasJournal of Oral Pathology & Medicine, 1989